An off-the-shelf stem cell therapy for type 1 diabetes continues to show positive results, according to a new study.

Dr. Ibon Garitaonandia, MBA, is the chief scientific officer at CellProthera, a clinical-stage biotech developing stem cell therapy for ischemic heart disease. In this article, Garitaonandia discusses ...

The promise of stem cell therapy is powerful. Scientists can draw versatile cells from the human body and deliver them to ...

Formation of human myocardium in the rat heart from human embryonic stem cells. Am. J. Pathol. 167(3), 663-671 (2005). Perin EC: The use of stem cell therapy for cardiovascular disease.

A new antibody treatment prevents cholesterol buildup in heart mitochondria and restores energy production, offering hope for ...

Showcased 7 presentations at ISSCR 2025, including a featured oral presentation on first-in-human gene therapy for heart ...

By Mohana Ravindranath The promise of stem cell therapy is powerful ... that have been reprogrammed into blank cells and then into heart cells may be able to restore some cardiac function.